HOTH vs QRVO · rev $1.24B vs P/E 27, rev $3.68B
Hoth Therapeutics Inc (HOTH) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
HOTH currently screens at market cap $15.5M. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the HOTH and QRVO stock pages for the full models.
Not investment advice.